Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 7 414 JPY -1.11% Market Closed
Market Cap: 593.1B JPY

Intrinsic Value

The intrinsic value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 6 955.33 JPY. Compared to the current market price of 7 414 JPY, Cosmos Pharmaceutical Corp is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6 955.33 JPY
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cosmos Pharmaceutical Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about Cosmos Pharmaceutical Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Cosmos Pharmaceutical Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cosmos Pharmaceutical Corp.

Explain Valuation
Compare Cosmos Pharmaceutical Corp to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Cosmos Pharmaceutical Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cosmos Pharmaceutical Corp

Current Assets 159.2B
Cash & Short-Term Investments 49.5B
Receivables 770m
Other Current Assets 108.9B
Non-Current Assets 365.1B
PP&E 336.8B
Intangibles 670m
Other Non-Current Assets 27.6B
Current Liabilities 216B
Accounts Payable 179B
Other Current Liabilities 37.1B
Non-Current Liabilities 45.6B
Long-Term Debt 36.1B
Other Non-Current Liabilities 9.5B
Efficiency

Free Cash Flow Analysis
Cosmos Pharmaceutical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cosmos Pharmaceutical Corp

Revenue
1T JPY
Cost of Revenue
-806.1B JPY
Gross Profit
215.9B JPY
Operating Expenses
-175.4B JPY
Operating Income
40.5B JPY
Other Expenses
-9.5B JPY
Net Income
31B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Healthy Gross Margin
Positive ROE
Positive 3Y Average ROIC
50/100
Profitability
Score

Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Cosmos Pharmaceutical Corp's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
77/100
Solvency
Score

Cosmos Pharmaceutical Corp's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Cosmos Pharmaceutical Corp

Wall Street analysts forecast Cosmos Pharmaceutical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 9 968.54 JPY with a low forecast of 8 080 JPY and a high forecast of 11 550 JPY.

Lowest
Price Target
8 080 JPY
9% Upside
Average
Price Target
9 968.54 JPY
34% Upside
Highest
Price Target
11 550 JPY
56% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Cosmos Pharmaceutical Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Cosmos Pharmaceutical Corp stock?

The intrinsic value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 6 955.33 JPY.

Is Cosmos Pharmaceutical Corp stock undervalued or overvalued?

Compared to the current market price of 7 414 JPY, Cosmos Pharmaceutical Corp is Overvalued by 6%.

Back to Top